Full Text View
Tabular View
No Study Results Posted
Related Studies
An Exploratory Study of Naltrexone Plus Aripiprazole for Alcohol Dependence (NALAPZ)
This study has been completed.
Study NCT00667875   Information provided by Medical University of South Carolina

First Received on April 24, 2008.   Last Updated on August 4, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Alcohol Dependence
Additional conditions recognized in this trial
Alcoholism
More general conditions related to this trial
Alcohol-Related Disorders
Mental Disorders
Substance-Related Disorders
Interventions listed in this trial
Placebo
Naltrexone
Naltrexone + Aripiprazole
Additional drug interventions recognized in this trial
Aripiprazole
More general drug interventions related to this trial
Antipsychotic Agents
Central Nervous System Agents
Central Nervous System Depressants
Narcotic Antagonists
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Sensory System Agents
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Medical University of South Carolina
National Institute on Alcohol Abuse and Alcoholism (NIAAA)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services